β2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk.
Liu B, Svenningsson P, Ludvigsson JF, Lundholm C, Wallin J, Larsson H, Sjölander A, Williams DM, Pedersen NL, Wirdefeldt K.
Liu B, et al.
Ann Neurol. 2023 May;93(5):1023-1028. doi: 10.1002/ana.26638. Epub 2023 Mar 23.
Ann Neurol. 2023.
PMID: 36897287
Free PMC article.